RSA Insurance Group plc:企業のM&A・事業提携・投資動向

◆英語タイトル:RSA Insurance Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1269
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

RSA Insurance Group plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s RSA Insurance Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by RSA Insurance Group plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes RSA Insurance Group plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by RSA Insurance Group plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on RSA Insurance Group plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by RSA Insurance Group plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for RSA Insurance Group plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about RSA Insurance Group plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 45
Corporate Venturing – Overview 45
Corporate Venturing – Deal reports 46
PARTNERSHIP 48
Partnership – Overview 48
Partnership – Deal reports 49
CAPITAL RAISING 52
Capital Raising – Overview 52
Capital Raising – Deal reports 53
DIVESTMENTS 55
Divestments – Overview 55
Divestments – Deal reports 56
PRIVATE EQUITY & OWNERSHIP 101
Private Equity and Ownership – Overview 101
Private Equity and Ownership – Deal reports 102
APPENDIX 104
Contact Us 104
About MarketLine Financial Deals Database 104
Deal Definition and Methodology 106
About MarketLine 113

List of Tables
Table 1: RSA Insurance Group plc corporate venturing volume and value trend (2014-YTD2018)
Table 2: RSA Insurance Group plc corporate venturing by geography (2014-YTD2018)
Table 3: RSA Insurance Group plc partnership volume and value trend (2014-YTD2018)
Table 4: RSA Insurance Group plc partnership trend by key deal type (2014-YTD2018)
Table 5: RSA Insurance Group plc capital raising volume and value trend (2014-YTD2018)
Table 6: RSA Insurance Group plc capital raising by deal type (2014-YTD2018)
Table 7: RSA Insurance Group plc divestments volume and value trend (2014-YTD2018)
Table 8: RSA Insurance Group plc divestments activity by geography (2014-YTD2018)
Table 9: RSA Insurance Group plc private equity and ownership volume and value trend (2014-YTD2018)
Table 10: RSA Insurance Group plc private equity and ownership activity by deal type (2014-YTD2018)

List of Figures
Figure 1: RSA Insurance Group plc corporate venturing volume and value trend (2014-YTD2018)
Figure 2: RSA Insurance Group plc corporate venturing by geography (2014-YTD2018)
Figure 3: RSA Insurance Group plc partnership volume and value trend (2014-YTD2018)
Figure 4: RSA Insurance Group plc partnership trend by key deal type (2014-YTD2018)
Figure 5: RSA Insurance Group plc capital raising volume and value trend (2014-YTD2018)
Figure 6: RSA Insurance Group plc capital raising by deal type (2014-YTD2018)
Figure 7: RSA Insurance Group plc divestments volume and value trend (2014-YTD2018)
Figure 8: RSA Insurance Group plc divestments by geography (2014-YTD2018)
Figure 9: RSA Insurance Group plc private equity and ownership volume and value trend (2014-YTD2018)
Figure 10: RSA Insurance Group plc private equity and ownership by deal type (2014-YTD2018)

★海外企業調査レポート[RSA Insurance Group plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • aTyr Pharma Inc (LIFE):製薬・医療:M&Aディール及び事業提携情報
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. The company’s ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to th …
  • Ichibanya Co Ltd:企業の戦略・SWOT・財務分析
    Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Ichibanya Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Progress Software Corp (PRGS):企業の財務・戦略的SWOT分析
    Progress Software Corp (PRGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • CardioComm Solutions Inc (EKG):医療機器:M&Aディール及び事業提携情報
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. The company offers software engineering of computer based electrocardiogram management and reporting software. …
  • Genesis Energy LP (GEL):企業の財務・戦略的SWOT分析
    Genesis Energy LP (GEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Brookfield Office Properties Inc:企業のM&A・事業提携・投資動向
    Brookfield Office Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Brookfield Office Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • Summit Therapeutics Plc (SUMM):企業の財務・戦略的SWOT分析
    Summary Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the in …
  • TALi Digital Ltd (NHL):企業の財務・戦略的SWOT分析
    TALi Digital Ltd (NHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …
  • Aptech Ltd (APTECHT):企業の財務・戦略的SWOT分析
    Aptech Ltd (APTECHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Emsland Group:企業の戦略・SWOT・財務分析
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務情報
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析
    Summary Pfizer Ltd India (Pfizer India), a subsidiary of Pfizer Inc, is a pharmaceutical company that develops medicines for brain disorders. The company’s products portfolio comprises of anti-allergics, anti-diabetics, anti-histamines, anti-infectives, anti-parasitics, drugs for cardiovascular and …
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Apple Inc:戦略・SWOT・企業財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Skechers USA Inc (SKX):企業の財務・戦略的SWOT分析
    Skechers USA Inc (SKX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PRA Health Sciences Inc (PRAH)-医療機器分野:企業M&A・提携分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization(CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometric …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆